Navigation Links
Paul Pospisil Joins Korn/Ferry as Senior Client Partner in Biotechnology and Life Sciences Practice
Date:1/6/2011

NEW YORK, Jan. 6, 2011 /PRNewswire/ -- Korn/Ferry International (NYSE: KFY), a premier global provider of talent management solutions, today announced that Paul Pospisil, Ph.D. has joined the Firm as a Senior Client Partner in the Biotechnology and Life Sciences Practice.  He will be based out of the Firm's New York office.

Mr. Pospisil joins Korn/Ferry after serving more than 15 years as an investor and operating executive in the biotechnology industry.  He brings to the Firm strong experience in drug discovery and development, finance, business development, technology assessment and evaluation, and business strategy.

Throughout his career, Mr. Pospisil has held senior-level positions at widely-regarded consulting and venture capital firms, as well as leading globally-focused biotechnology and bio-pharmaceutical organizations.

"Paul's unique credentials as both an investor and biotechnology executive, coupled with his vast knowledge of the issues and trends driving the industry, will be a great fit for our entrepreneurial life sciences clients," said Stephen Israel, Korn/Ferry's managing director, biotechnology and pharmaceuticals.

Mr. Pospisil joins the Firm from Aduro Capital LLC, an investment management company focused on the public healthcare sector and Aduro Partners LLC, an advisory firm focused on helping venture-backed and public life science companies assess, evaluate, partner opportunities and build businesses.  Previously, he was a partner in life science investments at Atlas Venture and earlier was with Millennium Pharmaceuticals, where his last position was director, strategy leadership.  Earlier, he was a new product manager at Altus Biologics, a spin-out of Vertex Pharmaceuticals.

Mr. Pospisil received a Ph.D. in Organic Chemistry from Harvard University and a Bachelor of Arts in Biochemistry from New York University.  He also attended Harvard Business School's Program for Management Development (PMD).

About Korn/Ferry International

Korn/Ferry International, with a presence throughout the Americas, Asia Pacific, Europe, the Middle East and Africa, is a premier global provider of talent management solutions. Based in Los Angeles, the firm delivers an array of solutions that help clients to attract, develop, retain and sustain their talent. Visit www.kornferry.com for more information on the Korn/Ferry International family of companies, and www.kornferryinstitute.com for thought leadership, intellectual property and research.


'/>"/>
SOURCE Korn/Ferry International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Jack Davis, Diagnostics Industry Executive, Joins the HistoRx Board of Directors
2. Dr. Russell L. Chapman Joins Aquatic Energy as the Chairman of its Science Advisory Board
3. Dr. Michael Hanley Joins Celtaxsys as CEO
4. Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
5. Distinguished Scientist H. Mario Geysen Joins SRI International to Lead Combinatorial Sciences and Metabolic Diseases Research Programs
6. Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services
7. Todd Park, Chief Technology Officer of U.S. Department of Health and Human Services, Joins Opening Keynote Line-Up at 2010 mHealth Summit
8. Heiner Dreismann, Ph.D., Former President of Roche Molecular Systems, Joins the HistoRx Board of Directors
9. Excerpta Medica Joins Adelphi Worldwide
10. Philadelphia Eagles Offensive Lineman Todd Herremans Joins SPO Medical to Endorse New SPO Wellness(TM) Product Line
11. Christopher Bowe Joins Scrip as US Healthcare Analyst
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... launched Rosalind™, the first-ever genomics analysis platform specifically designed for life science ... in honor of pioneering researcher Rosalind Franklin, who made a major contribution ...
(Date:10/11/2017)... CA, USA (PRWEB) , ... October 11, 2017 , ... ... to take place on 7th and 8th June 2018 in San Francisco, CA. The ... influencers as well as several distinguished CEOs, board directors and government officials from around ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the main ... people each year. Especially those living in larger cities are affected by air pollution ... of the most pollution-affected countries globally - decided to take action. , “I knew ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... 2017 Research and Markets has announced the ... to their offering. ... eye tracking market to grow at a CAGR of 30.37% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
Breaking Biology News(10 mins):